Shanghai, China

Xike Xu

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Xike Xu

Introduction

Xike Xu, an inventive mind based in Shanghai, China, has made significant strides in the field of biomedical innovations. With a total of three patents to his name, Xu's research focuses on therapeutic agents that show promise in treating severe heart and neurological conditions.

Latest Patents

Among Xike Xu's notable patents are "Line leaf inula flower lactone A and methods for preparing and using the same for treating myocarditis" and "Preparation and application of line leafflower lactone A for treating multiple sclerosis." The first patent describes a compound that demonstrates positive therapeutic activity against the Coxsackie virus and prevents disease in experimental autoimmune myocarditis models. Xu's research indicates that administering line leafflower lactone A via intraperitoneal injection poses significant benefits, particularly at dosages of 20 mg/kg/d and 100 mg/kg/d, showing robust therapeutic effects. Additionally, the compound is utilized in various pharmaceutical forms, including tablets and injections, allowing for versatile applications in treating myocarditis.

His second notable patent focuses on using line leafflower lactone A as a treatment for multiple sclerosis. The compound has shown therapeutic effects in experimental autoimmune encephalomyelitis (EAE) models, suggesting its potential for developing effective drugs for MS. This innovation is also adaptable for use in multiple pharmaceutical forms, enhancing its clinical application and value.

Career Highlights

Throughout his career, Xike Xu has worked with various organizations, including Shanxi Zhendong Pilot Biological Science and Technology Co., Ltd. His contributions to research and development in pharmaceuticals underline his commitment to advancing medical science and addressing critical health issues.

Collaborations

Xu has collaborated with notable researchers such as Weidong Zhang and Juan Su, further enriching his work through shared insights and expertise. These collaborations have played a significant role in the development of effective therapeutics, ensuring that his innovations reach their full potential.

Conclusion

Xike Xu's innovative research and patents highlight the potential impact of line leafflower lactone A in treating serious medical conditions like myocarditis and multiple sclerosis. His ongoing contributions to biomedical sciences exhibit a commitment to improving health outcomes through novel therapeutic inventions. As Xu continues to advance his work, the medical community eagerly anticipates the future applications of his innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…